Daratumumab plus bortezomib, melphalan, and prednisone in East Asian patients with non-transplant multiple myeloma: subanalysis of the randomized phase 3 ALCYONE trialOriginal Article Published on 2019-10-162024-09-02 Journal: Annals of Hematology [Category] 대상포진, [키워드] daratumumab Multiple myeloma Transplant-ineligible VMP [DOI] 10.1007/s00277-019-03794-9 PMC 바로가기 [Article Type] Original Article